pfizer austria

What pfizer austria does

Pfizer Austria, legally Pfizer Corporation Austria Gesellschaft m.b.H., is the Austrian operating arm of the global Pfizer Inc. group and a private limited liability company (GmbH) registered in Vienna with sole ownership held by Pfizer Luxembourg Sarl. The company markets more than 100 pharmaceutical medicines and vaccines in the Austrian market across multiple therapeutic areas, with distribution handled via its own distributor and an Orth an der Donau (Lower Austria) manufacturing site operated by the related entity Pfizer Manufacturing Austria GmbH, which focuses on vaccine and pharmaceutical production. Approximately 415 employees work across the Vienna headquarters and the Orth an der Donau production facility.

The business model is B2B distribution of regulated pharmaceutical products to three customer categories: full-range pharmaceutical wholesalers (vollsortierte pharmazeutische Großhändler), public pharmacies (Apotheken), and hospitals with institutional or designated consultant pharmacies (Anstaltsapotheke / Konsiliarapotheke). Orders are processed primarily through EDI, with email and written forms as alternatives, and pricing is communicated through regular information emails at depot ex-factory (DAP) prices; payment terms are 30 days net. Products are packaged for the Austrian market only and are subject to export restrictions outside the EEA, reflecting compliance with § 57 AMG authorized-recipient rules and the Austrian Hospitals Act (KAKuG).

The go-to-market is enterprise field sales supported by a Medical Information service, a Drug Safety / adverse-event reporting channel, and a quality complaints function. There is no public developer API or partner-facing technology platform; the company's proprietary footprint is its regulated distribution infrastructure, employer brand, and compliance framework rather than a software stack. Pfizer Austria does not disclose revenue, operating under the same confidentiality framework as its parent group, and its commercial trajectory is effectively tied to global Pfizer pipeline output and Austrian regulatory and reimbursement dynamics.

Name

pfizer austria

Legal name

Pfizer Corporation Austria Gesellschaft m.b.H.

Website

https://pfizer.at

Company type

Private

Operating status

Operating

Short description

Pfizer Austria is the Vienna-based Austrian subsidiary of Pfizer Inc., employing ~415 staff, marketing 100+ pharmaceutical medicines and vaccines, and manufacturing at Orth an der Donau for Austrian wholesalers, pharmacies, and hospitals.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Vaccine Fill-Finish, Packaging & Cold-Chain Formulation (vial/syringe, lyophilization, thermostable) (HLAAAEAJ)

Keywords

• Pharmaceutical medicines
• Vaccines manufacturing
• Prescription drugs
• Healthcare products
• Pharmaceutical distribution

Headquarters

HQ city

Breitenfurt Bei Wien

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of over 100 pharmaceutical medicines and vaccines registered in the Austrian market. Revenue generated from sales to pharmaceutical wholesalers, pharmacies, and hospitals.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Pfizer Austria develops, manufactures, and distributes over 100 registered pharmaceutical medicines and vaccines in the Austrian market. The company operates as the Austrian subsidiary of Pfizer Inc., serving patients and healthcare professionals through direct B2B sales to pharmaceutical wholesalers, pharmacies, and hospitals. It also operates a vaccine and pharmaceutical manufacturing site in Orth an der Donau.

Product overview

Pfizer Austria operates as a single-brand pharmaceutical company offering a portfolio of more than 100 prescription medicines and vaccines marketed in Austria. The products are made available through a product finder that provides information on active substances and applications. The company serves patients, medical professionals, and healthcare institutions through its Vienna headquarters and Orth an der Donau manufacturing site.

Differentiator

Problem solved

Functional benefit

Products and services

• Pfizer Arzneimittel (Pfizer Medicines) Portfolio of more than 100 pharmaceutical medicines and vaccines registered in the Austrian market, covering various therapeutic areas to protect patients from diseases, cure illnesses, or extend and significantly improve the lives of patients with serious diseases. Sold to pharmaceutical wholesalers, pharmacies, and hospitals.
• Medical Information Service Dedicated medical information contact channel for healthcare professionals and patients, accessible by phone (+43 1 521 15 0) and online forms. Provides product specifications, prescription guidance, and adverse event reporting support.
• Adverse Event Reporting Service Drug Safety Department contact point for healthcare professionals and patients to report adverse events (side effects) associated with Pfizer medicines. Reachable via [email protected] and phone.
• Product Complaint Handling (Reklamation) Quality Department service allowing customers to file product complaints or quality issues with Pfizer pharmaceutical products. Reachable via [email protected].

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered minor and core.

• PharmigminorOthersPfizer Corporation Austria is a member of Pharmig, the Austrian pharmaceutical industry association. Compliance with Pharmig Code of Conduct is referenced in the company's regulatory disclosures.
• Wirtschaftskammer Österreich (WKO)minorOthersPfizer Austria is a member of the Austrian Federal Economic Chamber, which promotes Austrian business interests.
• AGES (Bundesamt für Sicherheit im Gesundheitswesen)minorOthersRegulatory oversight body in Austria responsible for pharmaceutical safety and market authorization.
• Bundesministerium für Gesundheit und Frauen (BMGF)minorOthersAustrian Federal Ministry for Health, the primary regulatory authority overseeing pharmaceutical companies in Austria.
• Magistrat der Stadt WienminorOthersMunicipal authority of the City of Vienna acting as the trade licensing authority (Gewerbebehörde) for Pfizer Austria.
• Pfizer Luxembourg SarlcoreOthersPfizer Luxembourg Sarl is the sole shareholder (Gesellschafter) of Pfizer Corporation Austria Gesellschaft m.b.H. This represents the corporate ownership structure within the Pfizer group.
• Charta der VielfaltminorOthersPfizer Austria is a signatory of the Diversity Charter (Charta der Vielfalt) of the Austrian Federal Economic Chamber, a voluntary commitment to diversity.
• Pride Biz AustriaminorOthersPfizer Austria is an official Ally partner of Pride Biz Austria, the umbrella organization for LGBTQ+ in business and working life.
• #positivarbeiten InitiativeminorOthersPfizer Austria supports the #positivarbeiten initiative of the Austrian AIDS Hilfs organizations, promoting non-discriminatory treatment of HIV-positive people in the workplace.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Novartis Pharma Austria: Novartis Pharma Austria is the Austrian subsidiary of Novartis AG, one of the world's largest branded pharmaceutical companies. Directly comparable to Pfizer Austria in selling a broad portfolio of patented primary care and specialty medicines through the same wholesaler, pharmacy, and hospital channels in Austria.
• Roche Austria: Roche Austria is the Austrian subsidiary of F. Hoffmann-La Roche, a global innovator in pharmaceuticals and diagnostics. Comparable to Pfizer Austria in offering branded prescription medicines (including oncology and biologics) and selling to Austrian wholesalers, pharmacies, and hospitals via similar B2B distribution channels.
• MSD (Merck Sharp & Dohme) Austria: MSD Austria is the local subsidiary of Merck & Co., a major global innovator pharmaceutical company. Directly comparable in offering a diversified branded prescription portfolio (oncology, vaccines, primary care) distributed to the same Austrian healthcare customers through parallel commercial channels.
• AstraZeneca Austria: AstraZeneca Austria is the Austrian affiliate of AstraZeneca plc, a global biopharmaceutical company. Comparable in commercializing branded primary care, specialty, and oncology medicines to Austrian pharmacies, hospitals, and wholesalers under similar regulatory and reimbursement conditions.
• Sanofi-Aventis Austria: Sanofi-Aventis Austria is the Austrian subsidiary of Sanofi S.A., a major global pharmaceutical and vaccine company. Comparable to Pfizer Austria in operating across branded pharmaceuticals and vaccines, with similar customer segments (wholesalers, pharmacies, hospitals) and reliance on Austrian regulatory and reimbursement frameworks.
• GSK Pharma Austria (GlaxoSmithKline): GSK Pharma Austria is the Austrian affiliate of GSK plc, a global pharmaceutical and vaccine company. Directly comparable to Pfizer Austria in offering branded prescription medicines and vaccines through the same Austrian distribution channels, particularly competitive in vaccines and respiratory therapeutics.
• Boehringer Ingelheim Austria: Boehringer Ingelheim Austria is the Austrian subsidiary of Boehringer Ingelheim, a global research-driven pharmaceutical company. Comparable in offering a portfolio of branded prescription products (respiratory, cardiometabolic) distributed to Austrian wholesalers, pharmacies, and hospitals.
• Eli Lilly Austria: Eli Lilly Austria is the Austrian subsidiary of Eli Lilly and Company, a global innovator in pharmaceuticals. Comparable to Pfizer Austria in selling branded specialty and primary care medicines (diabetes, oncology, immunology) through similar B2B distribution channels in the Austrian market.
• AbbVie Austria: AbbVie Austria is the Austrian subsidiary of AbbVie Inc., a global research-based biopharmaceutical company. Comparable in commercializing patented branded medicines (immunology, oncology, aesthetics) to Austrian pharmacies and hospitals with parallel regulatory and reimbursement positioning to Pfizer Austria.
• Bayer Austria: Bayer Austria is the Austrian subsidiary of Bayer AG, a global pharmaceutical and life sciences company. Comparable to Pfizer Austria in selling a diversified branded prescription portfolio (including women's health, cardiology, and radiology) through the same Austrian wholesale, pharmacy, and hospital channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pfizer-corporation-austria-gesellschaft-m.b.h.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about pfizer austria